Clinical Trial

Monitoring Exhaled Breath to Noninvasively Detect Glycemic Events

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to determine whether an array of biosensors can noninvasively identify hyperglycemic or hypoglycemic events in persons diagnosed with diabetes through noninvasive detection of volatile organic compounds in exhaled breath.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-04-01 -> 2026-12-01 2026-05-14
minor Completion pushed: 2026-04-01 -> 2026-12-01 2026-05-14
Trial Details
NCT Number NCT06893341
Lead Sponsor Indiana University
Conditions Diabetes, Hyperglycemia, Hypoglycemia
Enrollment 30 participants
Start Date 2025-10-23
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-13